image
Syndax Pharmaceuticals, Inc. SNDX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.83
-5.72 %
$ 1.35 B
Market Cap
-4.31
P/E
BALANCE SHEET
613 M ASSETS
23.26%
Growth Rates
1Year 23.26%
3Years 26.80%
5Years 48.83%
7Years 27.98%
10Years 43.07%
58.7 M LIABILITIES
97.01%
Growth Rates
1Year 97.01%
3Years 6.61%
5Years 13.69%
7Years 13.05%
10Years 27.39%
554 M EQUITY
18.56%
Growth Rates
1Year 18.56%
3Years 30.01%
5Years 59.88%
7Years 30.90%
10Years 46.89%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Syndax Pharmaceuticals, Inc.
image
Current Assets 581 M
Cash & Short-Term Investments 578 M
Receivables 1.23 M
Other Current Assets 2.07 M
Non-Current Assets 32 M
Long-Term Investments 29.8 M
PP&E 1.5 M
Other Non-Current Assets 680 K
Current Liabilities 58.1 M
Accounts Payable 9.96 M
Short-Term Debt 1.05 M
Other Current Liabilities 47.1 M
Non-Current Liabilities 588 K
Long-Term Debt 588 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 295.4 74.4 222.0 115.2 24.6 33.8 35.2 23.8 23.2 10.0 10.1 0.5
Short Term Investments 282.2 410.0 218.0 177.8 35.2 47.1 94.8 81.5 64.1 2.2 4.2 91 K
Receivables 1.2 4.1 0.4 0.2 0.1 0.3 0.4 0.3 0.3 35 K 0 0
Inventory 0 (4.3) 7.7 5.3 1.7 1.1 (1.4) 2.4 0.3 51 K 0 0
Other Current Assets 2.1 9.9 7.9 5.6 2.4 2.1 3.0 2.9 1.2 0.1 0.3 0.1
Total Current Assets 580.9 481.3 448.4 298.9 62.3 83.3 133.4 108.5 88.0 12.4 14.5 0.7
PP&E 1.5 1.1 1.3 0.5 1.0 0.4 0.3 0.3 88 K 33 K 40 K 20 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 29.8 5.5 0 0.1 0.1 0 3.2 0 0 0 0 0
Other Long Term Assets 0.7 9.4 0 1.2 82 K 0.2 0.2 0.2 1.8 0.3 2.5 0.8
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 612.9 497.2 449.7 300.6 63.5 83.9 137.2 109.0 89.9 12.8 17.1 1.5
LIABILITIES
Accounts Payable 10.0 4.3 5.7 3.5 6.2 1.4 2.2 2.4 1.5 0.4 1.1 0.8
Short Term Debt 1.0 0.4 0.4 2.6 0.5 0 0 0 0 6.4 0 21.3
Other Current Liabilities 47.1 24.3 14.7 11.2 10.2 13.1 12.0 6.8 2.2 3.5 1.7 3.0
Total Current Liabilities 58.1 29.1 20.7 18.9 18.4 16.1 15.8 10.4 4.8 10.3 2.7 25.1
Long Term Debt 0.6 0.7 20.6 17.9 0.4 0 0 0 0 7.4 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 1 K 5 K 0.1 0.3 0.3 2.9 0.8 2.5 5.7
Total Liabilities 58.7 29.8 41.3 48.4 31.9 30.9 32.9 24.9 23.2 18.5 5.2 30.8
EQUITY
Common Stock 8 K 7 K 6 K 5 K 3 K 2 K 2 K 2 K 1 K 1 K 1 K 0
Retained Earnings (902.4) (693.0) (543.7) (568.6) (495.5) (439.4) (366.1) (305.3) (259.7) (159.8) (135.7) (79.1)
Other Accumulative Comprehensive Income/Loss 0.2 (0.8) 45 K 4 K 0 25 K (0.1) 56 K 28 K (0.2) (0.2) (0.2)
Total Equity 554.2 467.4 408.4 252.2 31.6 53.0 104.3 84.1 66.7 (5.7) 11.8 (29.3)
Total Liabilities and Equity 612.9 497.2 449.7 300.6 63.5 83.9 137.2 109.0 89.9 12.8 17.1 1.5
SHARES OUTSTANDING
Common Shares Outstanding 70.4 60.8 52.1 41.3 30.5 25.4 21.0 14.6 17.4 9.6 8.0 70.3